Immediate Impact

50 standout
Sub-graph 1 of 25

Citing Papers

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Glycan-specific molecularly imprinted polymers towards cancer diagnostics: merits, applications, and future perspectives
2024 Standout
2 intermediate papers

Works of Hidesuke Yanagida being referenced

[Two Patients with Recurrence of Hepatocellular Carcinoma after Liver Resection Who Achieved Long-Term Stable Disease with Small Doses of Sorafenib Therapy].
2015
Positive Status of α‐Fetoprotein and des‐γ‐Carboxy Prothrombin: Important Prognostic Factor for Recurrent Hepatocellular Carcinoma
2004

Author Peers

Author Last Decade Papers Cites
Hidesuke Yanagida 150 93 104 32 355
Liangshuo Hu 181 81 90 35 386
Wenying Zhou 105 105 71 37 398
Min Zhang 87 77 120 35 329
Yukiko Kosai‐Fujimoto 124 103 108 38 324
J. P. Hölzen 116 80 82 21 323
Ken Dabanaka 118 40 110 30 410
Wenli Yang 159 120 70 28 394
Long Cheng 142 46 73 22 313
H Tomoda 143 66 176 34 407
Fujio Matsumura 167 90 85 28 392

All Works

Loading papers...

Rankless by CCL
2026